Canada - Renin-Angiotensin System Medicine Use
Since 2014, Canada Renin-Angiotensin System Medicine Use was up 4% year on year. In 2019, the country was number 9 comparing other countries in Renin-Angiotensin System Medicine Use with 219.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Canada is overtaken by Lithuania, which was ranked number 8 at 221.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Slovakia at 213.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary topped the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +0.6% versus 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria witnessed the best average annual growth at +10.2% per year, while Chile was the worst growing country at -3.5% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 219.70 |
2018 | 211.20 |
2017 | 207.30 |
2016 | 206.10 |
2015 | 178.80 |
How does Canada rank in Renin-Angiotensin System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
8 |
#8
Lithuania
|
221 | 2019 | +1.2 % | +0.1 % | View data | |
9 |
#9
Canada
|
220 | 2019 | +4.0 % | +4.0 % | View data | |
10 |
#10
Slovakia
|
214 | 2019 | +3.7 % | +1.5 % | View data |